American International Group, Inc. Nex Immune, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $14,111 - $41,020	-8,765 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.79 - $4.65 $1,104 - $2,869	-617 Reduced 6.58%	8,765 $37,000
Q4 2021 Feb 11, 2022	SELL	$4.11 - $15.13 $1,150 - $4,236	-280 Reduced 2.9%	9,382 $43,000
Q3 2021 Nov 12, 2021	BUY	$10.32 - $16.9 $60,630 - $99,287	5,875 Added 155.14%	9,662 $146,000
Q2 2021 Aug 13, 2021	BUY	$14.98 - $23.89 $838 - $1,337	56 Added 1.5%	3,787 $62,000
Q1 2021 May 07, 2021	BUY	$17.95 - $25.91 $66,971 - $96,670	3,731 New	3,731 $71,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.